(Q24246681)

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Pentoxifylline increases cerebral blood flow in patients with cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Effect of oxpentifylline on blood viscosity and cerebral blood flow in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Treating acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Protection against ischemic brain damage using propentofylline in gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Effect of pentoxifylline on cerebral edema in cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

Effects of pentoxifylline on cerebral ultrastructure of normal and ischemic gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Effects of dipyridamole, pentoxifylline or dipyridamole plus pentoxifylline on platelet reactivity in patients with ischemic cerebrovascular insufficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

The effect of pentoxifylline on the energy metabolism of ischemic gerbil brain.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Use of pentoxifylline in the treatment of acute cerebrovascular insufficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Clinical experience with pentoxifylline in occlusive cerebrovascular disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Pentoxifylline in strokes: a clinical study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000162.PUB2

7 January 2021